Literature DB >> 26096076

Right Ventricular Structure and Function in Idiopathic Pulmonary Fibrosis with or without Pulmonary Hypertension.

Antonello D'Andrea1, Anna Stanziola2, Enza Di Palma1, Maria Martino2, Michele D'Alto1, Santo Dellegrottaglie3, Rosangela Cocchia1, Lucia Riegler1, Meredyth Vanessa Betancourt Cordido1, Maurizia Lanza2, Marco Maglione4, Veronica Diana1, Raffaele Calabrò1, Maria Giovanna Russo1, Mani Vannan5, Eduardo Bossone6.   

Abstract

AIMS: To elucidate right ventricular (RV) function in patients with idiopathic pulmonary fibrosis (IPF) with and without pulmonary hypertension (PH) and its relation to other features of the disease. METHODS AND
RESULTS: Clinical evaluation, standard Doppler echo, Doppler myocardial imaging (DMI), and 2D strain echocardiography (STE) of RV septal and lateral walls were performed in 52 IPF patients (66.5 ± 8.5 years; 27 males) and in 45 age- and sex-comparable controls using a commercial US system (MyLab Alpha, Esaote). Pulmonary artery mean pressure (mPAP) was estimated by standard echo Doppler. RV global longitudinal strain (RV GLS) was calculated by averaging RV local strains. The IPF patients were divided into 2 groups by noninvasive assessment of PH: no PH (mPAP<25 mmHg; 36 pts) and PH (mPAP ≥25 mmHg; 16 pts). Left ventricular diameters and ejection fraction were comparable between controls and IPF, while GLS was impaired in IPF (P < 0.01). RV end-diastolic diameters, wall thickness andmPAP were increased in IPF patients with PH. In addition, pulsed DMI detected in PH IPF impaired myocardial RV early diastolic (Em) peak velocity. Also peak systolic RV strain was reduced in basal and middle RV lateral free walls in IPF, as well as RV GLS (P < 0.0001). The impairment in RV wall strain was more evident when comparing controls with the no PH group than comparing the no PH group with the PH group. By multivariate analysis, independent association of RV strain with both six-minute walking test distance (P < 0.001), mPAP (P < 0.0001), as well as with forced vital capacity (FVC) % (P < 0.005) in IPF patients were observed.
CONCLUSIONS: Impaired RV diastolic and systolic myocardial function were present even in IPF patients without PH, which indicates an early impact on RV function and structure in patients with IPF.
© 2015, Wiley Periodicals, Inc.

Entities:  

Keywords:  Doppler myocardial imaging; echocardiography; idiopathic pulmonary fibrosis; pulmonary hypertension; right ventricle; speckle tracking strain

Mesh:

Year:  2015        PMID: 26096076     DOI: 10.1111/echo.12992

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  13 in total

1.  Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study.

Authors:  Yue Zhong; Wenjuan Bai; Qibing Xie; Jianhong Sun; Hong Tang; Li Rao
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-22       Impact factor: 2.357

2.  Pulmonary hypertension in patients with interstitial pneumonia with autoimmune features.

Authors:  Bashar N Alzghoul; Robert Hamburger; Thomas Lewandowski; Brandon Janssen; Daniel Grey; Wei Xue; Ali Ataya; Hassan Alnuaimat; Diana C Gomez-Manjarres; Divya Patel; Raju Reddy
Journal:  Pulm Circ       Date:  2020-12-07       Impact factor: 3.017

3.  Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Laith Alkukhun; Xiao-Feng Wang; Mostafa K Ahmed; Manfred Baumgartner; Marie M Budev; Raed A Dweik; Adriano R Tonelli
Journal:  Respir Med       Date:  2016-06-02       Impact factor: 3.415

4.  Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease.

Authors:  Hiroyuki Kamide; Shingo Kato; Keigo Hayakawa; Kazuki Fukui; Hideya Kitamura; Takashi Ogura; Tae Iwasawa; Kazuo Kimura; Kouichi Tamura; Daisuke Utsunomiya
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-28       Impact factor: 2.357

Review 5.  Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.

Authors:  Scott D Collum; Javier Amione-Guerra; Ana S Cruz-Solbes; Amara DiFrancesco; Adriana M Hernandez; Ankit Hanmandlu; Keith Youker; Ashrith Guha; Harry Karmouty-Quintana
Journal:  Can Respir J       Date:  2017-02-13       Impact factor: 2.409

Review 6.  Updated Perspectives on Pulmonary Hypertension in COPD.

Authors:  Isabel Blanco; Olga Tura-Ceide; Victor Ivo Peinado; Joan Albert Barberà
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-09

7.  Pulmonary hypertension in chronic lung disease and hypoxia.

Authors:  Steven D Nathan; Joan A Barbera; Sean P Gaine; Sergio Harari; Fernando J Martinez; Horst Olschewski; Karen M Olsson; Andrew J Peacock; Joanna Pepke-Zaba; Steeve Provencher; Norbert Weissmann; Werner Seeger
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

8.  Risk assessment in interstitial lung disease: the incremental prognostic value of cardiopulmonary ultrasound.

Authors:  Wei-Wei Zhu; Hong Li; Yi-Dan Li; Lanlan Sun; Lingyun Kong; Xiaoguang Ye; Qizhe Cai; Xiu-Zhang Lv
Journal:  BMC Pulm Med       Date:  2021-07-15       Impact factor: 3.317

9.  Right ventricular contractility decreases during exercise in patients with non-advanced idiopathic pulmonary fibrosis.

Authors:  Sandra de Barros Cobra; Marcelo Palmeira Rodrigues; Felipe Xavier de Melo; Nathali Mireise Costa Ferreira; César Augusto Melo-Silva
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

10.  Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases.

Authors:  Agostino Buonauro; Ciro Santoro; Maurizio Galderisi; Angelo Canora; Regina Sorrentino; Roberta Esposito; Maria Lembo; Mario Enrico Canonico; Federica Ilardi; Valeria Fazio; Bruno Golia; Alessandro Sanduzzi; Marialuisa Bocchino
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.